Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service? Thank you for choosing ACROBiosystems. Would you rate our product and service?
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
Human IL-1 RII, Fc Tag (Cat. No. IL2-H4256) captured on CM5 chip via Anti-human IgG Fc antibodies surface can bind Human IL-1 beta, His Tag (Cat. No. ILB-H51H3) with an affinity constant of 0.571 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
PG-201 | PG-201 | Approved | Viromed | Layla | South Korea | Osteoarthritis | Pmg Pharm Co Ltd | 2012-01-01 | Osteoarthritis | Details |
Edaravone/(+)-2-Decanol | SIM-071201; Y-2 | Approved | Jiangsu Simcere Pharmaceutical Co Ltd | Mainland China | Stroke | Nanjing Simcere Dongyuan Pharmaceutical Co Ltd | 2020-07-29 | Brain Infarction; Intracranial Hemorrhages; Cerebral Hemorrhage; Stroke; Alzheimer Disease; Amyotrophic Lateral Sclerosis | Details | |
Thalidomide | NSC-66847; NSC-527179; K-17; VP-02 | Approved | Celgene Corp | Talizer, Thalidomide Celgene, Thalidomide Pharmion, Synovir, Thalomid, Thaled | Japan | Leprosy, Lepromatous | Fujimoto Pharmaceutical | 1982-01-01 | Osteosarcoma; Leprosy, Lepromatous; Drug Resistant Epilepsy; Primary Myelofibrosis; Neuroectodermal Tumors, Primitive; Prostatitis; Colorectal Neoplasms; Lymphoma, Mantle-Cell; Sarcoma, Ewing; Retinoblastoma; Waldenstrom Macroglobulinemia; Cholangitis, Sclerosing; HIV Wasting Syndrome; Arachnoiditis; Adenocarcinoma, Clear Cell; Prostatic Neoplasms; Pancreatitis, Chronic; Lymphoma, Follicular; Sarcoma; Xerostomia; Burning Mouth Syndrome; Neoplasm Metastasis; Mycobacterium avium-intracellulare Infection; Vascular Malformations; Amyotrophic Lateral Sclerosis; Melanoma; Carcinoma, Hepatocellular; Leukemia, Lymphocytic, Chronic, B-Cell; Myelodysplastic-Myeloproliferative Diseases; Stomatitis; Erythema Nodosum; Anemia, Sideroblastic; Uterine Neoplasms; Lymphoma, Non-Hodgkin; Glioma; Angiodysplasia; Pelvic Pain; Appendiceal Neoplasms; Lung Neoplasms; Endometrial Neoplasms; Mycobacterium Infections; Gastric Antral Vascular Ectasia; Carcinoid Tumor; Lupus Erythematosus, Discoid; Stomatitis, Aphthous; Rhabdomyosarcoma; | Details |
Canakinumab | ACZ-885 | Approved | Novartis Pharma Ag | Ilaris | United States | Still's Disease, Adult-Onset | Novartis Pharma Ag | 2009-06-17 | Muscular Dystrophy, Duchenne; Hyperimmunoglobulin D syndrome; Mucocutaneous Lymph Node Syndrome; Cryopyrin-Associated Periodic Syndromes; Arthritis, Gouty; Coronavirus Infections; Cognitive Dysfunction; Sarcoidosis, Pulmonary; Alzheimer Disease; Urticaria; Primary Myelofibrosis; Dry Eye Syndromes; Pulmonary Disease, Chronic Obstructive; Gout; Carcinoma, Non-Small-Cell Lung; Macular Degeneration; Diabetes Mellitus; Behcet Syndrome; Diabetic Retinopathy; Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Peripheral Arterial Disease; Diabetes Mellitus, Type 2; Familial Mediterranean Fever; Hepatitis, Alcoholic; Prediabetic State; Diabetes Mellitus, Type 1; Atherosclerosis; Mevalonate Kinase Deficiency; Anemia; Schnitzler Syndrome; Pyoderma Gangrenosum; Polyarticular Juvenile Idiopathic Arthritis; Still's Disease, Adult-Onset; Polycythemia Vera; Arthritis, Rheumatoid; Myelodysplastic Syndromes; Hereditary Autoinflammatory Diseases; Vasculitis; Coronavirus Disease 2019 (COVID-19); Chronic Urticaria; Muckle-Wells Syn | Details |
Rilonacept | KPL-914; RGN-303 | Approved | Regeneron Pharmaceuticals Inc | Arcalyst | United States | Pericarditis | Regeneron Pharmaceuticals Inc | 2008-02-27 | Pericarditis; Renal Insufficiency, Chronic; Inflammation; Gout; Scleroderma, Diffuse; Urticaria; Cryopyrin-Associated Periodic Syndromes; Hearing Loss, Sensorineural; Genetic Diseases, Inborn; Familial Mediterranean Fever; Arthritis, Juvenile; Muckle-Wells Syndrome (MWS); Scleroderma, Systemic; Anemia; Schnitzler Syndrome; Diabetes Mellitus, Type 1; Still's Disease, Adult-Onset | Details |
Diacerein | AC-201; AC-203; Art-50; SF-277; CCP-020; KW-4800; AC-201CR | Approved | Verboril, Art, 安必丁, Artrodar, Artrolyt, Cartivix, Fisiodar | Epidermolysis Bullosa, Junctional; Overweight; Epidermolysis Bullosa Dystrophica; Diabetes Mellitus; Osteoarthritis, Hip; Obesity; Osteoarthritis; Arthritis; Diabetes Complications; Diabetes Mellitus, Type 2; Pemphigoid, Bullous; Osteoarthritis, Knee; Epidermolysis Bullosa; Epidermolysis Bullosa Simplex; Coronavirus Disease 2019 (COVID-19); Insulin Resistance; Non-alcoholic Fatty Liver Disease | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
HMPL-004 (Hutchison Medipharma) | HMPL-004 | Details | |||
LY 2189102 | LY-2189102 | Eli Lilly And Company | Details | ||
lutikizumab | ABT-981 | Abbvie Inc | Details | ||
CYT 013 IL1bQb | Kuros Biosciences | Details | |||
Ensereptide | PXL-01 | Phase 3 Clinical | Promore Pharma | Post-surgical adhesions; Cicatrix | Details |
DLX-2323 | DLX-2323 | Phase 1 Clinical | Delenex Therapeutics Ag | Inflammation | Details |
Ajulemic acid | DMH-11C; JBT-101; CPL-7075; DMH-THC-11-OIC; CT-3; HU-239; IP-751 | Phase 3 Clinical | Corbus Pharma | Cystic Fibrosis; Lupus Vulgaris; Dermatomyositis; Lupus Erythematosus, Systemic; Scleroderma, Diffuse | Details |
Goflikicept | RPH-104 | Phase 3 Clinical | Trpharm | Still's Disease, Adult-Onset; Familial Mediterranean Fever; Schnitzler Syndrome; ST Elevation Myocardial Infarction; Coronavirus Disease 2019 (COVID-19); Pericarditis; Gout | Details |
Efprezimod alfa | CD24-Fc; HAS-CD24; CD24-Fc-IgG; MK-7110; MK7110 | Phase 3 Clinical | Oncoimmune Inc | Leukemia; Hematopoietic stem cell transplantation (HSCT); HIV Infections; Solid tumours; Graft vs Host Disease; Coronavirus Disease 2019 (COVID-19); Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Dyslipidemias; Leukemia, Myeloid, Acute; Melanoma | Details |
Kinnazumab | Phase 2 Clinical | Changchun Genescience Pharmaceutical Co Ltd | Solid tumours; Still's Disease, Adult-Onset; Arthritis, Juvenile; Arthritis, Gouty; Gout | Details | |
AK-114 | AK-114; AK114 | Phase 1 Clinical | Zhongshan Akeso Biopharma Co Ltd | Solid tumours; Neoplasms; Inflammation; Neoplasm Metastasis | Details |
Gevokizumab | XMA-005.2; AB-7; XOMA-052; S-78989; VPM-087 | Phase 1 Clinical | Xoma Corp | Colonic Neoplasms; Labyrinth Diseases; Panuveitis; Behcet Syndrome; Osteoarthritis; Uveitis; Colorectal Neoplasms; Cryopyrin-Associated Periodic Syndromes; Arthritis, Rheumatoid; Diabetes Mellitus, Type 1; Hereditary Autoinflammatory Diseases; Diabetes Mellitus, Type 2; Pyoderma Gangrenosum; Esophageal Neoplasms; Carcinoma, Renal Cell; Stomach Neoplasms; Acne Vulgaris | Details |
Recombinant humanized monoclonal antibody antiIL-1β(Cp Guojian) | SSGJ-613 | Phase 2 Clinical | Shanghai Cp Guojian Pharmaceutical Co Ltd | Tumor necrosis factor receptor associated periodic syndrome; Arthritis, Juvenile; Arthritis, Gouty; Gout; Inflammation | Details |
FL-101 | FL-101 | Phase 1 Clinical | Flame Biosciences Inc | Urinary Bladder Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
CU-06 | CU-06-EYE; CU-06-IBD; CU-061004; Sac-1004; CU-06-ONCO; CU-06-HAE; CU06-1004 | Phase 2 Clinical | Curacle Co Ltd | Myocardial Infarction; Neoplasms; Lung Diseases; Stroke; Diabetic macular oedema; Colitis, Ulcerative; Macular Degeneration; Angioedemas, Hereditary; Crohn Disease; Diabetic Retinopathy | Details |
This web search service is supported by Google Inc.